CEL-SCI Corp (CVM)

8.54 -1.20  -12.32% NYSE AM Dec 3, 16:00 8.55 +0.01  +0.12% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All CVM News

News

View All Events

Events

Date Type Description
12/30/2021 Earnings Results Q4 2021 Earnings Results
08/16/2021 Earnings Results Q3 2021 Earnings Results
07/01/2021 04:00 EST AGM 2020 Annual General Meeting
05/18/2021 Earnings Results Q2 2021 Earnings Results
02/16/2021 Earnings Results Q1 2021 Earnings Results
12/30/2020 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
  • URL: https://www.cel-sci.com
  • Investor Relations URL: https://cel-sci.com/new-investor-information/
  • HQ State/Province: Virginia
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Dec. 30, 2021
  • Last Earnings Release: Aug. 16, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Aug. 28, 1996

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.